Scientists Crack the Code on Coating Living Cell Powerhouses Without Killing Them

A Breakthrough at the Cellular Level

For a long time, it was considered implausible: coating the outer surface of intact, functioning mitochondria with an engineered synthetic material while leaving the organelle's ability to generate energy fully intact. Now, a team of Italian researchers has pulled it off — and the implications for treating some of the most stubborn diseases in medicine could be profound.

Scientists from Politecnico di Milano and the IRCCS Fondazione Istituto Neurologico Carlo Besta conducted the work, through their joint BraiNs laboratory, established in 2023. The discovery was published on September 18, 2026, in the Journal of the American Chemical Society.

What They Did — and How

The material at the center of the study belongs to a family of compounds known as Metal-Organic Frameworks, or MOFs — crystalline structures built from metal ions or clusters connected by organic linker molecules, arranged in a repeating three-dimensional lattice. Specifically, the team used a variant called ZIF-8, wrapping it around isolated mitochondria taken from mouse liver tissue.

Harsh chemical conditions, osmotic stress, or physical disruption can quickly collapse the membrane potential that drives energy production, rendering the organelles useless. Any coating strategy must therefore be gentle enough to preserve the structural integrity and bioenergetic activity of the mitochondria while still forming a stable layer on their outer surface. The Italian team met this challenge by developing a method that uses relatively low concentrations of coating ingredients — because higher concentrations of certain chemicals can interfere with mitochondrial respiration.

What the Results Actually Showed

Basal respiration declined from 14.36 in uncoated mitochondria to 11.96 after coating, meaning the modified structures retained approximately 83 percent of their original activity. That's a meaningful preservation of function, not a perfect one — but the researchers consider it a significant proof of concept. The respiratory control ratio, another key measurement of mitochondrial function, changed only slightly — from 10.58 to 10.23 — a difference researchers found was not statistically significant.

Transplantation of the coated mitochondria into Mouse Embryonic Fibroblasts increased cellular respiratory capacity without affecting cell viability, indicating that the coating is biocompatible and does not impair mitochondrial uptake. In other words, the coated mitochondria didn't just survive the process — they were welcomed into other cells and actually boosted those cells' energy output.

Why This Matters for Human Disease

Mitochondria are often called the "powerhouses" of our cells, tiny structures that churn out the energy life needs. When they malfunction, the consequences can be devastating, especially for energy-hungry organs like the brain and muscles. Treatments for mitochondrial diseases remain scarce, but this breakthrough by scientists in Milan may open new possibilities.

These results provide a safe platform for the further engineering of delivery systems aimed at enhancing internalization efficiency in mitochondrial transplantation therapeutics. Essentially, the coating could one day act as a kind of protective shell that helps healthy mitochondria survive long enough to be delivered into damaged cells — a concept once confined to science fiction. Additional research will be necessary to establish whether coated mitochondria perform better during transplantation than mitochondria without a coating, but the foundation has now been laid. The question is no longer whether mitochondria can be modified without destroying them — it's how far that modification can ultimately take medicine.